Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Li-Chuen Wong

A/Prof Li-Chuen Wong

Eczema Practical Updates for General Practice

Dr Preeti Joshi

Dr Preeti Joshi

Cow’s Milk Allergy in Infants and Children

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

RSV Vaccine on the NIP – What You Need to Know

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Inhaler Devices Workshop

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023